ArticleSmall (Weinheim an der Bergstrasse, Germany)2025
Real-Time Monitoring of Atherosclerotic Plaque Using β-Galactosidase-Activated Photoacoustic Tomography.
Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nanotechnology for atherosclerotic plaque stabilisation: bridging innovation and clinical practice.EBioMedicine · 2026Review
- Real-Time Monitoring of Atherosclerotic Plaque Using β-Galactosidase-Activated Photoacoustic Tomography.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
The early monitoring and risk assessment of atherosclerotic progression is crucial yet challenging due to its intricate and dynamic pathological process. A lipo-nanoprobe incorporating chlorophyll derivatives is developed, which enables enzyme-triggered in situ J-aggregation-induced red-shift, allowing detection at 710 nm with a linear relationship to senescence-associated β-galactosidase (SA-β-gal), an essential marker of atherosclerotic formation and progression. The photoacoustic histological analysis conducted using the nanoprobe confirmed the accurate visualization of plaque microenvironment SA-β-gal activity, enabling semi-quantitation of plaque progression at different time points. By employing dynamic multi-wavelength imaging, the nanoprobe presented a specific SA-β-gal-dependent absorption at 710 nm in vivo. Utilizing photoacoustic tomography imaging, 3D images of plaques were reconstructed and quantitative analysis was performed on the extent and distribution of senescence in the total aortic vascular wall. The monitored signal revealed significant trends in relation to cellular senescence phenotype, particularly in vascular smooth muscle cells (VSMCs), which are crucial for clinically assessing the impact of cellular processes that contribute to plaque formation and expansion during the progression of atherosclerosis. This study demonstrates the utility of SA-β-gal-responsive photoacoustic imaging for detecting plaque pathological progression and highlights its advantage for early monitor plaque formation in individuals at risk of developing atherosclerosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.